Primary Objective:~To examine the safety and feasibility of Y-90 TARE directed to the right hemi-liver for induction of left liver FLR hypertrophy as part of a planned hepatectomy for patients with CLM.~Secondary Objectives:~To describe changes in liver volume after Y-90 TARE, including:~The kinetic growth rate (KGR) of the FLR~Degree of hypertrophy 6 weeks after TARE~Atrophy of targeted right hemi-liver from TARE date to date of surgery~To describe additional interventional procedures needed to induce additional hypertrophy if insufficient hypertrophy from Y-90 TARE~To assess the proportion of TARE patients who undergo attempted and complete curative-intent resection of CLM~To assess measures of disease control, including:~Tumor marker trend~RECIST/mRECIST criteria~CT morphologic response~PET CT response~To describe Patient Reported Outcomes using MDASI-GI~To assess FLR liver quality, right-sided surgical adhesions from TARE intraoperatively~To describe dosimetry of individual liver lesions - using SPECT/CT, CT, and pathology correlation~To describe change in liver function measured by the pre- and post-TARE HIDA SPECT/CT scans and hepatic function blood tests
A prospective, interventional study evaluating the safety of Y-90 TARE for tumor control of the right side and induction of left liver hypertrophy as part of a planned single-stage or two-stage hepatectomy for patients with CLM and insufficient FLR at the time of presentation.